3rd Quarter - Amendment

CURE SMA for CURE SMA

Firm
Client
Income
—
Expenses
$60,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report Oct 21, 2019 $60,000 Replaced
3rd Quarter - Amendment (this page) Jan 30, 2020 $60,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

biomedical research funding, newborn screening appropriations

LobbyistCovered position, as disclosed
MAYNARD FRIESZ New Leg. Asst & Dir. Special Projects, Sen. Byron Dorgan, Jan. 1998 to May 2010

Contacted: Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); SENATE

Health Issues HCR

newborn screening, biomedical research funding

LobbyistCovered position, as disclosed
MAYNARD FRIESZ New Leg. Asst & Dir. Special Projects, Sen. Byron Dorgan, Jan. 1998 to May 2010

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.